Urinary epidermal growth factor levels in patients with acute renal failure.
To investigate the importance of epidermal growth factor (EGF) in patients with renal dysfunction, urinary human EGF (hEGF) levels were determined by radioimmunoassay in 16 patients with acute renal failure (ARF) and in 12 healthy controls. Seven patients with chronic renal failure also were studied. Urinary hEGF levels, corrected for urine creatinine concentrations, were significantly decreased in patients with ARF in the acute phase compared with normal control subjects (0.98 +/- 0.20 v 13.74 +/- 1.18 ng/mg creatinine, P < 0.001), and subsequently increased during the recovery phase (6.10 +/- 0.73 ng/mg creatinine, P < 0.001 v acute phase). A significant positive correlation existed between urinary hEGF levels and creatinine clearance in patients with ARF (r = 0.66, P < 0.001). Serum hEGF levels also were significantly lower in patients with ARF compared with normal control subjects (0.10 +/- 0.01 v 0.30 +/- 0.03 ng/mL, P < 0.001). No significant correlation was found between hEGF concentrations in serum and urine. In conclusion, measurement of urinary hEGF may be useful in the diagnosis of ARF and for following the recovery of the kidney after severe tubular injury.
Taira
T
T
Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Yoshimura
A
A
Iizuka
K
K
Iwasaki
S
S
Ideura
T
T
Koshikawa
S
S
D058186:Acute Kidney Injury / Q000503:physiopathology / Q000652:urine*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D004815:Epidermal Growth Factor / Q000652:urine*; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D011863:Radioimmunoassay
D004815:Epidermal Growth Factor